findmyKOL
Clinical trialNCT00268138UnknownPhase 4Interventional

Elmex Gel Efficacy in Preventing White Spot Lesions

SponsorHadassah Medical OrganizationEnrollment314Dental Caries
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

the objective of this phase IV study: to establish the efficacy of elmex gel with a fluoride concentration of 1.25% compared with placebo by determining prevention of white spot lesions in patients wearing fixed orthodontic appliances.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Meir Redlich, DMD PhD

    Hadassah Medical Center, Dept of Orthodontics

    Principal Investigator
  • Paul George Jost-Brinkmann, Prof

    Charite - Berlin, Dept of Orthodontics, Center of Dentistry

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Charite University

    Berlin, Germany

    Recruiting
Israel
  • Hadassah Medical Organization, Jerusalem, Israel

    Jerusalem, Israel

    Meir Redlich, DMD PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Elmex gel
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2006
Primary completion
31 Dec 2010
Completion
31 Dec 2010
Last update posted
18 Feb 2009
Registered enrollment
314
Registry id
NCT00268138

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.